Date: 07 May 2009
Link: FDA Warning Letter (New Window)
Observation4. Failure to routinely calibrate, inspect, or check according to a written program designed to assure proper performance of automatic, mechanical, or electronic equipment, including computers, used in the manufacture, processing, packing and holding of a drug product. [21 CFR 211.68]
Part A
A. The Enterprise Resource Planning
Wednesday, 19 May 2010
CSV FDA Warning Letters : ERP and Calibration
Posted on 10:23 by Unknown
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment